Totally Robotic Distal Gastrectomy: A Safe and Feasible Minimally Invasive Technique for Gastric Cancer Patients Who Undergo Distal Gastrectomy.
Adenocarcinoma
/ pathology
Adult
Aged
Anastomosis, Surgical
Blood Loss, Surgical
Conversion to Open Surgery
Disease-Free Survival
Feasibility Studies
Female
Gastrectomy
/ adverse effects
Humans
Length of Stay
Male
Middle Aged
Operative Time
Postoperative Complications
/ etiology
Retrospective Studies
Robotic Surgical Procedures
/ adverse effects
Stomach
/ surgery
Stomach Neoplasms
/ pathology
Survival Rate
Distal gastrectomy
Gastric cancer
Robotic-assisted distal gastrectomy
Safe
Totally robotic distal gastrectomy
Journal
Digestive surgery
ISSN: 1421-9883
Titre abrégé: Dig Surg
Pays: Switzerland
ID NLM: 8501808
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
12
2019
accepted:
06
04
2020
pubmed:
20
6
2020
medline:
6
8
2021
entrez:
20
6
2020
Statut:
ppublish
Résumé
To explore the safety and feasibility of totally robotic distal gastrectomy (TRDG) for gastric cancer patients who undergo distal gastrectomy. Consecutive patients with gastric cancer who underwent TRDG (TRDG group) and robotic-assisted distal gastrectomy (RADG) (RADG group) were systematically reviewed at the Second Xiangya Hospital of Central South University from October 2015 to August 2018. Data were collected and statistically analyzed. A total of 161 consecutive patients were included in this study: 84 cases in the TRDG group and 77 in the RADG group. Clinical characteristics and pathological results were mostly similar in both groups. The TRDG group had a significantly longer anastomotic time (20.6 ± 3.3 vs. 17.5 ± 4.0 min, p ˂ 0.001) but showed no difference in total operating time (167.0 ± 18.0 vs. 162.9 ± 17.6 min, p = 0.159). The postoperative hospitalization in the TRDG group was shorter than that in the RADG group (6.7 ± 1.2 vs. 7.2 ± 1.7 days, p = 0.019). Conversion rate, estimated blood loss, and postoperative complications were similar in both groups. There were no statistical differences in the estimated 2-year disease-free survival and overall survival rate between both groups. Although our current results need to be verified in further studies, TRDG represents a safe and feasible approach to distal gastrectomy and embodies the theory of minimally invasive surgery.
Identifiants
pubmed: 32554961
pii: 000507809
doi: 10.1159/000507809
pmc: PMC7592952
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
360-367Informations de copyright
The Author(s). Published by S. Karger AG, Basel.
Références
Gastric Cancer. 2011 Oct;14(4):365-71
pubmed: 21573920
World J Gastroenterol. 2017 Jun 21;23(23):4293-4302
pubmed: 28694670
Chirurg. 2017 Jan;88(Suppl 1):12-18
pubmed: 27380211
World J Gastrointest Endosc. 2017 Jan 16;9(1):1-11
pubmed: 28101302
Surg Endosc. 2016 Feb;30(2):574-580
pubmed: 26208497
J Laparoendosc Adv Surg Tech A. 2018 Sep;28(9):1109-1114
pubmed: 30088978
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
Cancer Epidemiol. 2016 Sep;44 Suppl 1:S62-S73
pubmed: 27678324
World J Gastroenterol. 2017 Dec 28;23(48):8553-8561
pubmed: 29358863
Ann Surg. 2016 Aug;264(2):214-22
pubmed: 27115899
Surg Endosc. 2015 Mar;29(3):673-85
pubmed: 25030478
Surg Laparosc Endosc Percutan Tech. 2017 Aug;27(4):e87-e91
pubmed: 28731955
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Surg Endosc. 2019 Feb;33(2):528-534
pubmed: 30014325
J Am Coll Surg. 2002 Aug;195(2):284-7
pubmed: 12168979
Scand J Surg. 2017 Mar;106(1):3-20
pubmed: 26929289
JSLS. 2015 Oct-Dec;19(4):
pubmed: 26941544
World J Surg. 2018 Jun;42(6):1803-1810
pubmed: 29134310
Surg Endosc. 2015 Dec;29(12):3768-75
pubmed: 25791064